Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Immunoconjugates × Clear all

NCT04829604 2026-03-09

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis